David Rubenstein
@davidrubenstein·310K subscribers·1.5K videos
Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks
Posted
January 8, 2025
Views
956
Likes
16
Comments
1
Engagement
January 8, 2025
956
16
1
1.78%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:19Now PlayingEli Lilly is the world's most valuable drug company, partially known for blockbuster anti-obesity drugs that are transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how GLP-1 anti-obesity medications work and Lilly's plans to develop a pill. Ricks also discusses the side effects that come from taking these drugs. This interview was recorded on December 10 at the Economic Club of Washington DC.
--------
Like this video? Subscribe to The David Rubenstein Show on YouTube:
Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
Learn more about David:
Connect with us on...
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
